Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
暂无分享,去创建一个
J. Finke | J. O’Shea | P. Rayman | R. Bukowski | R. Tubbs | L. Rybicki | M. Cathcart | B. Roy | L. Rybicki | V. Kolenko | Biswajit Roy
[1] H. Slegers,et al. Cyclic AMP‐mediated induction of the glial fibrillary acidic protein is independent of protein kinase A activation in rat C6 glioma , 1997, Journal of neuroscience research.
[2] S. Sorota,et al. Modulation of dog atrial swelling‐induced chloride current by cAMP: protein kinase A‐dependent and ‐independent pathways. , 1997, The Journal of physiology.
[3] J. Johnston,et al. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. , 1996, Immunity.
[4] A. Tamir,et al. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. , 1996, Journal of immunology.
[5] Y. Shintani,et al. Regulation of chloride channel trafficking by cyclic AMP via protein kinase A-independent pathway in A6 renal epithelial cells. , 1996, Biochemical and biophysical research communications.
[6] J. Johnston,et al. Analysis of Interleukin-2-dependent Signal Transduction through the Shc/Grb2 Adapter Pathway , 1995, The Journal of Biological Chemistry.
[7] W. Leonard,et al. Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.
[8] P. Doherty,et al. Defective Lymphoid Development in Mice Lacking Jak3 , 1995, Science.
[9] A. Sharpe,et al. Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3 , 1995, Science.
[10] J. Ihle. Cytokine receptor signalling , 1995, Nature.
[11] Y. Minami,et al. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Rees,et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Greenberg,et al. Interleukin 2 signaling involves the phosphorylation of Stat proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Myles,et al. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. , 1995, Journal of immunology.
[15] R. Perlmutter,et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation , 1995, Cell.
[16] J. Blenis,et al. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP , 1995, Molecular and cellular biology.
[17] T. Taniguchi,et al. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. , 1995, Immunity.
[18] I. Kerr,et al. Activation of JAK kinases and STAT proteins by interleukin‐2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. , 1994, The EMBO journal.
[19] O. Silvennoinen,et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.
[20] J. Gribben,et al. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. , 1994, Science.
[21] J. Johnston,et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.
[22] N. Tanaka,et al. Interleukin 2‐induced activation of JAK3: Possible involvement in signal transduction for c‐myc induction and cell proliferation , 1994, FEBS letters.
[23] K. Sugamura,et al. Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex , 1994 .
[24] W. Farrar,et al. Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. , 1994, The Journal of biological chemistry.
[25] E. Liu,et al. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells , 1994, Nature.
[26] J. Johnston,et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 , 1994, Nature.
[27] J. Johnston,et al. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] Kendall A. Smith,et al. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells , 1994, The Journal of experimental medicine.
[29] B. Nelson,et al. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation , 1994, Nature.
[30] M. Erdos,et al. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling , 1994, Nature.
[31] A. Tamir,et al. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. , 1994, Journal of immunology.
[32] D. Chen,et al. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles , 1994, The Journal of experimental medicine.
[33] K. Arai,et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.
[34] D. Longo,et al. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. , 1993, Cancer research.
[35] T. Taniguchi,et al. The IL-2 IL-2 receptor system: A current overview , 1993, Cell.
[36] W. Leonard,et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.
[37] T. Taniguchi,et al. The IL-2 receptor complex: its structure, function, and target genes. , 1993, Annual review of immunology.
[38] N. Tanaka,et al. Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.
[39] M. Alava,et al. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1. , 1992, The Biochemical journal.
[40] F. Paliogianni,et al. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. , 1992, Journal of immunology.
[41] O. Majdic,et al. In vitro and in vivo activated T cells display increased sensitivity to PGE2. , 1991, Cellular immunology.
[42] R. Perlmutter,et al. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.
[43] M. Brann,et al. Expression of GTP-binding proteins and prostaglandin E2 receptors during human T cell activation. , 1991, Cellular immunology.
[44] L. Davis,et al. Delineation of the mechanism of inhibition of human T cell activation by PGE2. , 1990, Journal of immunology.
[45] K. Smith,et al. cAMP regulation of IL-2 receptor expression. Selective modulation of the p75 subunit. , 1990, Journal of immunology.
[46] E. Gelfand,et al. Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation. , 1990, Journal of immunology.
[47] G. Crabtree,et al. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.
[48] T. Mustelin,et al. Molecular events mediating T cell activation. , 1990, Advances in immunology.
[49] T. Taniguchi,et al. A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization , 1989, Cell.
[50] W. Schaffner,et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.
[51] A. López-Rivas,et al. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells , 1988, European journal of immunology.
[52] K. Smith,et al. cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. Kammer. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. , 1988, Immunology today.
[54] J. Allison,et al. Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation. , 1986, Journal of immunology.
[55] G. R. Dodge,et al. Prostaglandin E inhibits the production of human interleukin 2 , 1982, The Journal of experimental medicine.
[56] R. Messner,et al. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell , 1977, The Journal of experimental medicine.